{{Rsnum
|rsid=261902
|Gene=BICD1
|Chromosome=12
|position=32323793
|Orientation=minus
|GMAF=0.1832
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=BICD1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 68.1 | 29.2 | 2.7
| HCB | 75.2 | 22.6 | 2.2
| JPT | 77.0 | 21.2 | 1.8
| YRI | 74.8 | 23.1 | 2.0
| ASW | 64.9 | 33.3 | 1.8
| CHB | 75.2 | 22.6 | 2.2
| CHD | 71.6 | 24.8 | 3.7
| GIH | 66.3 | 32.7 | 1.0
| LWK | 67.9 | 28.4 | 3.7
| MEX | 36.2 | 51.7 | 12.1
| MKK | 64.7 | 32.1 | 3.2
| TSI | 70.6 | 28.4 | 1.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Normalized brain volume
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000004
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs261902
|Name_s=
|Gene_s=BICD1
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 753 cases, 883 controls; Replication Sample Size: NR); (Region: 12p11.21; Reported Gene(s): BICD1; Risk Allele: rs261902-?); (p-value= 0.000004).This variant is associated with Normalized brain volume.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740737
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs261902
|overall_frequency_n=103
|overall_frequency_d=128
|overall_frequency=0.804688
|n_genomes=54
|n_genomes_annotated=0
|n_haplomes=85
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}